These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30366590)

  • 1. Plaque Psoriasis Flare and Peripheral Edema in a Patient Treated With Atezolizumab.
    Santos-Juanes J; Munguía Calzada P; Álvarez Fernández C
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):410-411. PubMed ID: 30366590
    [No Abstract]   [Full Text] [Related]  

  • 2. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
    Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
    Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
    [No Abstract]   [Full Text] [Related]  

  • 3. Debut Of Inflammatory Bowel Disease Associated To Ixekizumab In Patient With Moderate, Difficult -To-Manage Psoriasis.
    Merino Gallego E; Gómez Torres K; Martínez Amate E
    Gastroenterol Hepatol; 2020 Dec; 43(10):622-623. PubMed ID: 32674878
    [No Abstract]   [Full Text] [Related]  

  • 4. A Case of Ixekizumab-induced Psoriasiform Eruption.
    Oiwa T; Fujita M; Takase S; Nishimura Y; Ota M; Okada K; Tachibana T
    Acta Derm Venereol; 2019 Apr; 99(4):446-447. PubMed ID: 30723870
    [No Abstract]   [Full Text] [Related]  

  • 5. Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series.
    Napolitano M; Scalvenzi M; Fabbrocini G; Cinelli E; Patruno C
    Dermatol Ther; 2019 Nov; 32(6):e13142. PubMed ID: 31664761
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
    Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
    Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.
    Mielke F; Schneider-Obermeyer J; Dörner T
    Ann Rheum Dis; 2008 Jul; 67(7):1056-7. PubMed ID: 18556453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Docetaxel-induced psoriasis].
    Allende I; González-Hermosa R; Lázaro M; Díaz-Pérez JL
    Actas Dermosifiliogr; 2009 Sep; 100(7):629-30. PubMed ID: 19715656
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab.
    Sato M; Yamamoto T
    An Bras Dermatol; 2024; 99(5):786-788. PubMed ID: 38945752
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy.
    Lo JA; Fisher DE; Flaherty KT
    JAMA Oncol; 2015 Dec; 1(9):1340-1. PubMed ID: 26270186
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocrelizumab-induced psoriasiform dermatitis in a patient with multiple sclerosis.
    Darwin E; Romanelli P; Lev-Tov H
    Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab-induced psoriasiform rash in rheumatoid arthritis.
    Palmou-Fontana N; Sánchez Gaviño JA; McGonagle D; García-Martinez E; Iñiguez de Onzoño Martín L
    Dermatology; 2014; 228(4):311-3. PubMed ID: 24942661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psoriasis-like eruption induced by adalimumab in a patient with rheumatoid arthritis : a case report and review of literature].
    Kuno H; Kotani T; Takeuchi T; Wakura D; Wakura R; Yu A; Makino S; Moriwaki S; Hanafusa T
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):520-5. PubMed ID: 23291487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of new-onset psoriasis while on anti-TNFalpha treatment.
    Matthews C; Rogers S; FitzGerald O
    Ann Rheum Dis; 2006 Nov; 65(11):1529-30. PubMed ID: 17038454
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffuse psoriasis induced by docetaxel in a 62-year-old woman with breast carcinoma.
    Mapelli ET; Gualandri L; Menni S; Cerri A
    G Ital Dermatol Venereol; 2016 Jun; 151(3):309-10. PubMed ID: 27176084
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-17 Monoclonal Antibody Successfully Treated Psoriasiform Drug Eruption Induced by Immune Checkpoint Inhibitors: A Case Report and Review of Literature.
    Li M; Yu S; Zhang G; Xie Y; Wei JC
    Dermatitis; 2024; 35(4):410-412. PubMed ID: 37934278
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.
    Jawed SI; Busam K; Wang X; Horwitz S; Querfeld C
    JAMA Dermatol; 2014 Sep; 150(9):1021-3. PubMed ID: 25029560
    [No Abstract]   [Full Text] [Related]  

  • 18. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
    Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
    Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset psoriasis induced by rituximab therapy for non-Hodgkin lymphoma in a child.
    Kim DW; Park SK; Woo SH; Yun SK; Kim HU; Park J
    Eur J Dermatol; 2016 Apr; 26(2):190-1. PubMed ID: 26771919
    [No Abstract]   [Full Text] [Related]  

  • 20. Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).
    Du-Thanh A; Girard C; Pageaux GP; Guillot B; Dereure O
    Eur J Dermatol; 2013; 23(6):900-1. PubMed ID: 24184416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.